and overall women ’ s health . services further .
Emmes appoints Peter Ronco as CEO
Parexel appoints Gwyn Bebb to lead oncology clinical development
SParexel , the world ’ s leading largest clinical research organizations ( CROs ) providing the full range of Phase I to IV clinical development services , has announced the appointment of Gwyn Bebb , BM , BCh ., Ph . D ., as Senior Vice President and Global Therapeutic Area Head – Oncology . In this role Dr . Bebb will lead the research and development of new cancer treatments for biopharmaceutical customers worldwide .
“ The complexities of oncology require agile , multifaceted teams to push the boundaries of drug development and deliver groundbreaking treatment options for patients with cancer ,” said Amy McKee , M . D ., Chief Medical Officer and Head , Oncology Center of Excellence .
Emmes , a global , full-service Clinical Research Organization ( CRO ), has appointed Peter Ronco as its Chief Executive Officer . Peter Ronco succeeds Dr Christine Dingivan , who will now serve as a senior advisor to Executive Chairman Sastry Chilukuri , and Emmes ’ Board of Directors .
Ronco is a global pharmaceutical executive with experience in a number of R & D leadership positions over more than two decades . He most recently served as Senior Vice President , Global Development at Johnson & Johnson , responsible for the design and delivery of a drug development portfolio of more than 500 active clinical studies across all therapeutic areas and phases of development . He has also held senior roles with Bristol Myers-Squibb , Accenture and Pfizer .
“ I am excited to welcome Peter to the Emmes team ,” said Kyle Peterson , Managing Director at New Mountain Capital and member of the Board of the Directors of Emmes .
BIOVOICENEWS . COM 65